Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Feasibility and patient satisfaction with smoking cessation interventions for prevention of healthcare-associated infections in inpatients.

Schulte DM, Duster M, Warrack S, Valentine S, Jorenby D, Shirley D, Sosman J, Catz S, Safdar N.

Subst Abuse Treat Prev Policy. 2016 Apr 26;11:15. doi: 10.1186/s13011-016-0059-0.

2.

Mortality and economic burden of Krasnoyarsk region, Russia, caused by regular tobacco usage.

Artyukhov IP, Arshukova IL, Dobretsova EA, Shulmin AV.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 22;11:351-5. doi: 10.2147/COPD.S97287.

3.

Four Principles to Consider Before Advising Women on Screening Mammography.

Keen JD, Jørgensen KJ.

J Womens Health (Larchmt). 2015 Nov;24(11):867-74. doi: 10.1089/jwh.2015.5220. Review.

4.

Smoking-attributable medical expenditures by age, sex, and smoking status estimated using a relative risk approach.

Maciosek MV, Xu X, Butani AL, Pechacek TF.

Prev Med. 2015 Aug;77:162-7. doi: 10.1016/j.ypmed.2015.05.019.

5.

Comparison of True and Smoothed Puff Profile Replication on Smoking Behavior and Mainstream Smoke Emissions.

Brinkman MC, Kim H, Chuang JC, Kroeger RR, Deojay D, Clark PI, Gordon SM.

Chem Res Toxicol. 2015 Feb 16;28(2):182-90. doi: 10.1021/tx500318h.

6.

A cost-effectiveness analysis of the first federally funded antismoking campaign.

Xu X, Alexander RL Jr, Simpson SA, Goates S, Nonnemaker JM, Davis KC, McAfee T.

Am J Prev Med. 2015 Mar;48(3):318-25. doi: 10.1016/j.amepre.2014.10.011.

7.

The impact of life tables adjusted for smoking on the socio-economic difference in net survival for laryngeal and lung cancer.

Ellis L, Coleman MP, Rachet B.

Br J Cancer. 2014 Jul 8;111(1):195-202. doi: 10.1038/bjc.2014.217.

8.

Lung cancer screening with low-dose computed tomography for primary care providers.

Richards TB, White MC, Caraballo RS.

Prim Care. 2014 Jun;41(2):307-30. doi: 10.1016/j.pop.2014.02.007. Review.

9.

New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidence.

Rudel RA, Ackerman JM, Attfield KR, Brody JG.

Environ Health Perspect. 2014 Sep;122(9):881-95. doi: 10.1289/ehp.1307455. Review.

10.

Abdominal aortic aneurysm screening: how many life years lost from underuse of the medicare screening benefit?

Olchanski N, Winn A, Cohen JT, Neumann PJ.

J Gen Intern Med. 2014 Aug;29(8):1155-61. doi: 10.1007/s11606-014-2831-z.

11.

Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers.

Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, Ozanne E, Peters E, Timmermans D, Woloshin S.

BMC Med Inform Decis Mak. 2013;13 Suppl 2:S7. doi: 10.1186/1472-6947-13-S2-S7. Review.

12.

Life gain in Italian smokers who quit.

Carrozzi L, Falcone F, Carreras G, Pistelli F, Gorini G, Martini A, Viegi G.

Int J Environ Res Public Health. 2014 Feb 26;11(3):2395-406. doi: 10.3390/ijerph110302395. Erratum in: Int J Environ Res Public Health. 2014 Jun;11(6):5970-4.

13.

Lung cancer screening.

Gutierrez A, Suh R, Abtin F, Genshaft S, Brown K.

Semin Intervent Radiol. 2013 Jun;30(2):114-20. doi: 10.1055/s-0033-1342951. Review.

14.

Development of a personalized decision aid for breast cancer risk reduction and management.

Ozanne EM, Howe R, Omer Z, Esserman LJ.

BMC Med Inform Decis Mak. 2014 Jan 14;14:4. doi: 10.1186/1472-6947-14-4.

15.

Cost-effectiveness of extended cessation treatment for older smokers.

Barnett PG, Wong W, Jeffers A, Munoz R, Humfleet G, Hall S.

Addiction. 2014 Feb;109(2):314-22. doi: 10.1111/add.12404.

16.

Examining the nature of the association between attention-deficit hyperactivity disorder and nicotine dependence: a familial risk analysis.

Biederman J, Pettye CR, Hammerness P, Woodworth KY, Faraon SV.

Can J Psychiatry. 2013 Mar;58(3):177-83.

17.

Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.

Aberle DR, Abtin F, Brown K.

J Clin Oncol. 2013 Mar 10;31(8):1002-8. doi: 10.1200/JCO.2012.43.3110. Review.

18.

Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.

Wang LE, Gorlova OY, Ying J, Qiao Y, Weng SF, Lee AT, Gregersen PK, Spitz MR, Amos CI, Wei Q.

Cancer Res. 2013 Jan 1;73(1):256-64. doi: 10.1158/0008-5472.CAN-12-1915.

19.

Clinical applications of gene-based risk prediction for lung cancer and the central role of chronic obstructive pulmonary disease.

Young RP, Hopkins RJ, Gamble GD.

Front Genet. 2012 Oct 16;3:210. doi: 10.3389/fgene.2012.00210.

20.

No increased mortality with early aortic aneurysm disease.

Mell M, White JJ, Hill BB, Hastie T, Dalman RL; Stanford Abdominal Aortic Aneurysm Specialized Center of Clinically Oriented Research Investigators..

J Vasc Surg. 2012 Nov;56(5):1246-51. doi: 10.1016/j.jvs.2012.04.023.

Supplemental Content

Support Center